16 December 2019 - The newly passed House bill allowing Medicare negotiations on drug prices is a first step toward taming Big Pharma and broader corporate abuse.
Last week's House vote to rein in skyrocketing prescription drug prices was overdue. Now it's up to the Senate and President Donald Trump to take action.
Working families and seniors are struggling to pay for the high cost of often life-saving medicines, and have been for years. But price gouging isn’t the only way big drug corporations rip off the American people. Congress needs to stop other abuses, too —starting with the drug industry’s rampant tax dodging.